RYTHM, Inc. (RYM): Nasdaq/NYSE listing notice — Agrify receives Nasdaq notice for late Q3 2023 10-Q; delisting risk persists

RYTHM, Inc.

Received Nasdaq notice on Nov 16, 2023 for failing to timely file Q3 2023 Form 10-Q.
Company is delinquent on FY2022 10-K, Q1, Q2, and Q3 2023 filings; remains noncompliant with Listing Rule 5250(c)(1).
Nasdaq Hearings Panel granted a stay of suspension pending a hearing; no immediate delisting effect.
Company intends to complete and file delinquent reports but provides no assurance of timeline.
Previously restated 2022 interim financials for warrant accounting errors; filed amended Q1-Q3 2022 on Oct 2, 2023.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

RYTHM, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

ents as of and for the quarterly periods ended March 31, 2022, June 30, 2022 and September 30, 2022 included in the Company’s Quarterly Reports on Form 10-Q for such periods in amended quarterly reports for the affected periods. As disclosed by the Company on its Notification of Late Filing on Form 12b-25 filed with the SEC on March 31, 2023, August 21, 2023, and November 15, 2023, the Company was unable to timely file the Form 10-K, the First Quarter Form 10-Q, the Second Quarter Form 10-Q and the Third Quarter Form 10-Q without unreasonable effort or expense. The November Nasdaq Notice noted

View on SEC.gov

Browse all listing & compliance notices →

RYTHM, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-089611

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.